Characterizing the Safety Profile of Apixaban Versus Warfarin in Moderate to Severe Chronic Kidney Disease at a Veterans Affairs Hospital

Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease

(2018) Joseph H. Schafer et al.   ANNALS OF PHARMACOTHERAPY

Re: Chokesuwattanaskul et al. Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis

(2018) Dena E. Rifkin   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients

(2017) Thomas A. Mavrakanas et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH

(2016) K. Martin et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis

(2015) Xiaoli Wang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

(2013) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban for Extended Treatment of Venous Thromboembolism

(2012) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Notice

(2012)   Kidney International Supplements

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

(2011) John H. Alexander et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE